European Healthtech startup funding raised during September 2015.
In September 2015, 26 European Healthtech companies raised a combined €184M across 26 funding rounds, up 356.1% versus September 2014. Denmark led by capital raised, and Accel Partners was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Symphogen | Debt | Sep 2015 | €68M |
| Minoryx Therapeutics | Series A | Sep 2015 | €19M |
| Doctolib | Series B | Sep 2015 | €18M |
| Euroscreen | Series B |
| Sep 2015 |
| €16M |
| Gamida Cell | Growth/Late | Sep 2015 | €13M |
| Pharmalink | Growth/Late | Sep 2015 | €11M |
| Sequana Medical | Series C | Sep 2015 | €8.3M |
| Mologic | Early VC | Sep 2015 | €4.1M |
| SmartZyme Innovation | Early VC | Sep 2015 | €3.6M |
| Univercells | Early VC | Sep 2015 | €3.0M |
| TNI medical | Early VC | Sep 2015 | €3.0M |
| Puridify | Series A | Sep 2015 | €3.0M |
| Simris Alg | Seed | Sep 2015 | €2.9M |
| Nuritas | Series A | Sep 2015 | €2.9M |
| Min Doktor | Early VC | Sep 2015 | €2.3M |
